EssilorLuxottica (OTCMKTS:ESLOY) Sees Large Volume Increase – Here’s What Happened

Shares of EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) saw strong trading volume on Thursday . 331,646 shares traded hands during trading, an increase of 201% from the previous session’s volume of 110,267 shares.The stock last traded at $136.59 and had previously closed at $138.50.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on ESLOY shares. UBS Group upgraded shares of EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. HSBC upgraded EssilorLuxottica from a “hold” rating to a “buy” rating in a research report on Wednesday, January 14th. Citigroup restated a “buy” rating on shares of EssilorLuxottica in a research note on Thursday, December 11th. Royal Bank Of Canada reissued an “outperform” rating on shares of EssilorLuxottica in a report on Tuesday, October 28th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Two research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, EssilorLuxottica has an average rating of “Buy”.

EssilorLuxottica Price Performance

The firm has a fifty day moving average price of $157.26 and a 200 day moving average price of $163.39. The company has a quick ratio of 0.67, a current ratio of 0.97 and a debt-to-equity ratio of 0.18.

About EssilorLuxottica

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.